Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study

Authors: Peter Thuss‐Patience, Manish A. Shah, Atsushi Ohtsu, Eric Van Cutsem, Jaffer A. Ajani, Hugo R. Castro, Wasat Mansoor, Hyun Cheol Chung, G. Bodoky, Kohei Shitara, Gail D. Lewis Phillips, T. van der Horst, Marie-Laurence Harle-Yge, Betsy Althaus, Yoon‐Koo Kang - The Lancet 2017 cited by 541